Physician profile
Mayur Patel
NPI 1639262751
$14,605.73
in general payments reported to CMS, 2019-2025
75 companies · $4,145 in 2025
The $4,145 reported for 2025 was more than what a typical Medical Oncology provider received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $970 · 2020: $920 · 2021: $1,196 · 2022: $2,012 · 2023: $2,199 · 2024: $3,163 · 2025: $4,145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,969 · Education: $538.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,968.70 |
| Education | $537.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,579.10 | 2019-2025 | |
| Genentech USA, INC. | $983.43 | 2019-2025 | Polivy, Venclexta, Lunsumio |
| Daiichi Sankyo INC. | $854.23 | 2020-2025 | Enhertu, Datroway, Vanflyta |
| Incyte Corporation | $724.93 | 2019-2025 | Monjuvi, Pemazyre, Jakafi |
| E.R. Squibb & Sons, L.L.C. | $660.88 | 2019-2025 | Opdualag, Opdivo |
| Merck Sharp & Dohme LLC | $632.52 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Astellas Pharma US INC | $502.04 | 2019-2025 | Xtandi, Padcev |
| Celgene Corporation | $501.60 | 2019-2025 | Reblozyl, Pomalyst, Opdivo |
| Pfizer INC. | $477.82 | 2019-2025 | |
| Amgen INC. | $453.62 | 2019-2023 | Nplate, Vectibix, Xgeva |
| Janssen Biotech, INC. | $448.57 | 2019-2025 | Carvykti, Imbruvica, Talvey |
| Genzyme Corporation | $436.71 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $335.91 | 2019-2025 | Ninlaro, Fruzaqla, Alunbrig |
| Aveo Pharmaceuticals, INC. | $327.01 | 2021-2025 | Fotivda |
| Karyopharm Therapeutics INC. | $282.99 | 2023-2025 | Xpovio |
Show all 75 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sobi, INC | $262.26 | 2022-2025 | |
| Seagen INC. | $246.73 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $244.33 | 2019-2023 | Xarelto |
| Eisai INC. | $211.42 | 2019-2024 | |
| Glaxosmithkline, LLC. | $201.01 | 2022-2025 | Ojjaara |
| Beigene USA, INC. | $197.98 | 2020-2025 | Brukinsa, Tevimbra |
| Lilly USA, LLC | $197.76 | 2019-2024 | Verzenio, Jaypirca, Retevmo |
| Exelixis INC. | $196.65 | 2019-2025 | Cabometyx |
| Pharmaessentia USA Corporation | $194.27 | 2022-2025 | Besremi |
| Jazz Pharmaceuticals INC. | $192.35 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $187.66 | 2023-2025 | Enhertu, Imfinzi, Tagrisso |
| Beone Medicines USA, INC. | $185.92 | 2025 | Brukinsa |
| Pharmacyclics LLC, An Abbvie Company | $180.11 | 2020-2023 | Imbruvica |
| Array Biopharma INC | $167.02 | 2022-2025 | Braftovi, Mektovi, Tukysa |
| Abbvie INC. | $158.60 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $148.56 | 2022-2025 | Libtayo |
| Emd Serono, INC. | $147.20 | 2023-2024 | Tepmetko, Bavencio |
| Taiho Oncology, INC. | $120.55 | 2019-2025 | |
| Dova Pharmaceuticals | $115.27 | 2020-2021 | |
| Gilead Sciences, INC. | $103.52 | 2019-2025 | Trodelvy |
| Sanofi-Aventis U.S. LLC | $99.95 | 2021 | |
| Ipsen Biopharmaceuticals, INC | $97.92 | 2022 | |
| Caris Mpi, INC. | $89.86 | 2025 | Mi Cancer Seek |
| Legend Biotech USA INC. | $85.36 | 2025 | Carvykti |
| Azurity Pharmaceuticals, INC. | $81.10 | 2025 | Danziten |
| Blueprint Medicines Corporation | $75.37 | 2024-2025 | Ayvakit |
| Pharmacosmos Therapeutics INC. | $73.78 | 2022-2025 | Monoferric |
| Stemline Therapeutics INC. | $73.61 | 2024-2025 | Orserdu |
| Tersera Therapeutics LLC | $70.71 | 2024-2025 | Zoladex |
| Boston Scientific Corporation | $68.00 | 2022-2024 | Wavewriter Alpha Prime 16 |
| Sumitomo Pharma America, INC. | $67.26 | 2024-2025 | Orgovyx |
| Amag Pharmaceuticals, INC. | $59.94 | 2021-2022 | |
| Verastem, INC. | $54.87 | 2019 | |
| Servier Pharmaceuticals LLC | $49.27 | 2024-2025 | |
| Agios Pharmaceuticals, INC. | $48.03 | 2025 | Pyrukynd |
| Alexion Pharmaceuticals, INC. | $43.32 | 2019-2025 | Ultomiris |
| Myriad Genetic Laboratories, INC. | $39.91 | 2022-2025 | Myrisk |
| Geron Corporation | $39.42 | 2025 | Rytelo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.46 | 2025 | |
| Puma Biotechnology, INC. | $37.13 | 2019-2024 | |
| Mylan Institutional INC. | $36.75 | 2021 | |
| Morphosys, US INC. | $35.42 | 2021 | |
| Tempus Ai, INC | $34.69 | 2024 | |
| Iovance Biotherapeutics, INC. | $28.16 | 2025 | Amtagvi |
| Alnylam Pharmaceuticals INC. | $25.92 | 2025 | Givlaari |
| Adc Therapeutics America, INC. | $24.57 | 2024 | |
| Acrotech Biopharma INC. | $24.16 | 2025 | Beleodaq |
| Genmab U.S., INC. | $23.41 | 2025 | Epkinly |
| Bayer Healthcare Pharmaceuticals INC. | $21.91 | 2023 | |
| Janssen Scientific Affairs, LLC | $21.89 | 2025 | Erleada |
| Novocure INC. | $21.80 | 2025 | Optune Lua (Novottf-200t) |
| Apellis Pharmaceuticals, INC. | $19.38 | 2024 | Empaveli |
| Rigel Pharmaceuticals, INC. | $19.10 | 2023 | Tavalisse, Rezlidhia |
| Accord Healthcare, INC. | $18.37 | 2025 | |
| Mirati Therapeutics, INC. | $17.76 | 2024 | Krazati |
| Recordati_rare_diseases_inc. | $17.00 | 2024 | Sylvant |
| Portola Pharmaceuticals, LLC | $16.78 | 2019 | |
| Foundation Medicine, INC. | $16.52 | 2023 | Foundationone Liquid Cdx |
| Kyowa Kirin, INC. | $15.65 | 2025 | |
| Kite Pharma, INC. | $12.69 | 2021 |
Drugs and devices associated with these payments
Enhertu $627Kisqali $462Keytruda $366Polivy $314Fotivda $299Xpovio $283Brukinsa $261Tukysa $255Imbruvica $224Venclexta $216Xtandi $204Carvykti $198Ibrance $196Lunsumio $184Tecentriq $177Pluvicto $175Besremi $171Padcev $171Doptelet $169Ojjaara $169Columvi $169Scemblix $168Zepzelca $153Reblozyl $147Braftovi $145Mektovi $145Monjuvi $139Alecensa $126Pemazyre $125Jakafi $124Lynparza $119Fabhalta $115Libtayo $113Piqray $107Pomalyst $104Erleada $95.94Orgovyx $94.18Epkinly $92.95Phesgo $91.44Ayvakit $89.88Mi Cancer Seek $89.86Sarclisa $89.03Lenvima $88.87Cabometyx $87.88Talvey $87.02Darzalex $87.02Ninlaro $81.39Danziten $81.10Fruzaqla $79.89Lutathera $78.71Xgeva $74.42Vectibix $74.42Nplate $74.42Opdivo $74.22Orserdu $73.61Zoladex $70.71Tecvayli $66.95Datroway $65.90Alunbrig $64.85Vanflyta $51.77Promacta $51.71Vonjo $51.38Trodelvy $49.78Tibsovo $49.27Wavewriter Alpha Prime 16 $48.51Perjeta $48.37Kadcyla $48.37Pyrukynd $48.03Inqovi $47.32Lonsurf $47.32Jaypirca $47.23Verzenio $47.23Rybrevant $45.92Mekinist $42.99Lorbrena $40.82Rytelo $39.42Opdualag $39.21Monoferric $38.01Tasigna $31.88Welireg $31.63Enjaymo $31.45Cablivi $31.45Rozlytrek $31.06Tepmetko $30.96Amtagvi $28.16Talzenna $26.92Keytruda Qlex $26.50Wayrilz $26.43Tevimbra $26.24Givlaari $25.92Abecma $24.58Myrisk $24.18Beleodaq $24.16Vpriv $24.10Tafinlar $21.93Vitrakvi $21.91Stivarga $21.91Bavencio $21.81Optune Lua (Novottf-200t) $21.80Tecentriq Hybreza $21.36
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mayur Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.